Vimarsana
Biggest News Aggregation in the World

Patent Pick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent Pick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Pick Today - Breaking & Trending Today

Oobleq Highlights Simple Starch Hydrogel Deodorant - Vimarsana News

Oobleq Highlights Simple Starch Hydrogel Deodorant

Metaperspirant is a simple starch-based hydrogel that acts in several ways to prevent odor. Per Oobleq, one is by forming a film and adhering to odor-causing bacteria to prevent them from cleaving the precursors found in apocrine sweat.

Kynurenines, Layered SPF, Red Algae and More: Sunscreen Patent Roundup - Vimarsana News

Kynurenines, Layered SPF, Red Algae and More: Sunscreen Patent Roundup

The Universities of Princeton and Utah, L'Oréal, Unilever, Kolmar Korea, Athena, Shiseido, Murata Manufacturing, LG Household & Health and Beiersdorf, among others, have recently published patents related to sunscreen innovation. Following is a roundup.

Spider Silk-inspired Programmable Textile Aids in Wound Care - Vimarsana News

Spider Silk-inspired Programmable Textile Aids in Wound Care

Research published in Advanced Functional Materials describes an artificial spider silk protein (spidroin) woven into a textile with biochemical sensing abilities, air permeability and motion monitoring that aids in wound healing.

Patent Pick: The Estée Lauder Cos. on Low-temp Water-resistant Matte Cosmetics - Vimarsana News

Patent Pick: The Estée Lauder Cos. on Low-temp Water-resistant Matte Cosmetics

A recent patent application from the Estée Lauder Cos. describes a mattifying film composition for skin or hair that can be easily removed using water above a certain temperature but not below it.

FDA Approves First Systemic Alopecia Areata Treatment - Vimarsana News

FDA Approves First Systemic Alopecia Areata Treatment

Olumiant is a Janus kinase (JAK) inhibitor, which blocks the activity of one or more of a specific family of enzymes, interfering with the pathway that leads to inflammation to thereby treat patients with alopecia areata.